Skip to main content
Yuyu Pharma, Inc. logo

Yuyu Pharma, Inc. — Investor Relations & Filings

Ticker · 000220 ISIN · KR7000220004 KO Manufacturing
Open in API
Filings indexed 303 across all filing types
Latest filing 2026-05-15 Interim / Quarterly Rep…
Country KR South Korea
Listing KO 000220

About Yuyu Pharma, Inc.

https://www.yuyu.co.kr/

Yuyu Pharma, Inc., established in 1941, is a healthcare company focused on the development, manufacturing, and marketing of pharmaceutical products. The company is committed to creating innovative therapeutics to address healthcare challenges and improve quality of life. Its research and development efforts are concentrated on key therapeutic areas, with a notable emphasis on treatments for central nervous system disorders, including Alzheimer's disease. The company operates through several divisions, including Yuyu Healthcare, which provides pharmaceutical-standard Original Design Manufacturer (ODM) and Original Equipment Manufacturer (OEM) services.

Recent filings

Filing Released Lang Actions
분기보고서 (2026.03)
Interim / Quarterly Report Classification · 92% confidence The document is titled “분기보고서” (Quarterly Report) for the 87th fiscal period covering January 1, 2026 to March 31, 2026, submitted to the Financial Supervisory Service and Korea Exchange. It contains detailed financial and corporate information, including consolidated subsidiaries, capital changes, share counts, and other interim financial disclosures. This matches the definition of an Interim/Quarterly Report (Code: IR). Q1 2026
2026-05-15 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 94% confidence The document is titled “주식등의 대량보유상황보고서(일반)” (Report on Large Holdings of Shares) under Korean capital markets law. It provides detailed disclosure of an individual and related parties’ shareholdings, changes in share numbers and ratios, and reasons for the change. This matches a notification of changes in significant share ownership levels. Hence, it is a Major Shareholding Notification.
2026-04-21 Korean
최대주주등소유주식변동신고서
Major Shareholding Notification Classification · 90% confidence The document is a ‘최대주주등소유주식변동신고서’ (Major Shareholder Stock Ownership Change Report) detailing changes in holdings by the company’s largest shareholder and related parties. This matches the definition of a Major Shareholding Notification (MRQ), which covers official disclosures of significant share ownership changes.
2026-04-21 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is titled “정기주주총회결과” (Regular General Meeting Results) and contains detailed vote outcomes for each agenda item, election results for directors and auditors, dividend approvals, and related meeting data. This clearly aligns with the definition of “Declaration of Voting Results & Voting Rights Announcements,” which covers official results from shareholder votes at general meetings. It is not the full annual report, audit report, or proxy materials but specifically the post‐AGM vote results.
2026-03-26 Korean
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Board/Management Information Classification · 87% confidence The document is a formal notification to the Financial Services Commission/Korea Exchange regarding the appointment, reappointment, or resignation of outside directors (“사외이사의 선임ㆍ해임 또는 중도퇴임에 관한 신고”). It details changes in board composition, dates of appointment, terms, and director backgrounds. This falls squarely under announcements of changes in the company’s board of directors, matching the “Board/Management Information” category.
2026-03-26 Korean
기업가치제고계획(자율공시)
Share Issue/Capital Change Classification · 68% confidence The document is a voluntary disclosure of a ‘corporate value enhancement plan’ by YuYu Pharma, detailing intentions to cancel treasury shares and increase dividends (i.e., changes to the company’s share capital structure). This is not an actual earnings release, annual report, or proxy statement, but it is an announcement of an upcoming capital change (share cancellation). Therefore, it best fits the Share Issue/Capital Change category (SHA).
2026-03-24 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.